OOIR: Observatory of International Research

Papers

(The median citation count of Biologicals is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Aims and Scope/Editorial Board/Publishing Details	21
Rationale for supporting stepwise access to safe plasma proteins through local production in low- and middle-income countries: A commentary of an international workshop	21
EGF domain peptide of Developmentally regulated endothelial locus1 facilitates gene expression of extracellularly applied plasmid DNA	15
The development and establishment of a heat inactivated preparation of Mycobacterium tuberculosis (H37Rv) as the first international standard for nucleic acid amplification techniques	12
Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: Reports from a series of NC3Rs stakeholder workshops	12
Nanoparticle formulation for the development of a dog nanovaccine against Cystic Echinococcosis	11
Potential therapeutic effects of hAMSCs secretome on Panc1 pancreatic cancer cells through downregulation of SgK269, E-cadherin, vimentin, and snail expression	11
A validated polyclonal antiserum-based immunoassay for assessment of HPV 16 L1 relative potency	11
Production and characterization of monoclonal antibodies against hepatitis B e-antigen and their potential application for development of HBeAg detection ELISA	11
Outer membrane vesicles as nanovaccine candidates against pathogenic Leptospira in experimental Guinea pig model	11
Aims and Scope/Editorial Board/Publishing Details	10
Glycosylation differences of an anti-VEGF monoclonal antibody (PRO-169) and its extensive comparison with Bevacizumab	9
Global availability of critical reagents for biologicals testing - Current status, challenges and possible solutions	8
Vaccination and surveillance for high pathogenicity avian influenza in poultry—current situation and perspectives	8
Validation of a next generation sequencing method for adventitious virus detection: Demonstration of sensitivity in multiple cell lines	8
A species-independent indirect-ELISA for detection of antibodies to the non-structural protein 2B of foot-and-mouth disease virus	8
Regulatory workshop on challenge strain development and GMP manufacture – A stakeholder meeting report	8
Nano-emulsion encapsulation for the efficient delivery of bacteriophage therapeutics	7
Ethical approval for controlled human infectious model clinical trial protocols – A workshop report	7
Replacement of in vivo leptospirosis vaccine potency testing in the United States	7
Animal cell substrates for the production of biologicals: An introduction to WHO documents	7
Establishing potency and stability release specifications using alternative ATP assay of BCG Tokyo 172-1 vaccine used in Thailand	7
The future of pyrogenicity testing: Phasing out the rabbit pyrogen test. A meeting report	7
Evaluation of candidate International Standards for meningococcal capsular polysaccharide groups W and Y	6
In silico discovery of epitopes of gag and env proteins for the development of a multi-epitope vaccine candidate against Maedi Visna Virus using reverse vaccinology approach	6

Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals	6
IABS/DCVMN webinar on next generation sequencing	6
Collaborative study for the calibration of a replacement International Standard for Diphtheria Antitoxin Equine	6
Accelerating Global Deletion of the Abnormal Toxicity Test for vaccines and biologicals. Planning common next steps. A workshop Report	6
A rapid and simple sterility test method based on solid culture medium containing blood	6
Novel vaccine candidates of Bordetella pertussis identified by reverse vaccinology	5
Evaluation of the focus reduction neutralization and ELISA tests compared to the plaque reduction neutralization test for the detection of antibodies against measles virus	5
Expression profiling of inflammation-related genes including IFI-16, NOTCH2, CXCL8, THBS1 in COVID-19 patients	5
Aims and Scope/Editorial Board/Publishing Details	5
Development and comparison of three cell-based potency assays for anti-respiratory syncytial virus monoclonal antibody	5
Development and evaluation of an external quality control and internal quality control containing real-time RT-PCR assay for the detection of o'nyong-nyong virus	5
Mass spectrometry analysis of bovine tuberculins - 3R potential in batch potency testing	4
Aims and Scope/Editorial Board/Publishing Details	4
Aims and Scope/Editorial Board/Publishing Details	4
Designing multi-epitope vaccine against human cytomegalovirus integrating pan-genome and reverse vaccinology pipelines	4
Future of TABST and LABST in the Indian Pharmacopoeia Monographs A Humane Society International/India Workshop Report	3
Animal experiments show impact of vaccination on reduction of SARS-CoV-2 virus circulation: A model for vaccine development?	3
Aims and Scope/Editorial Board/Publishing Details	3
Prevalence of viral agents causing swine reproductive failure in Korea and the development of multiplex real-time PCR and RT-PCR assays	3
Development of an optimized RT-LAMP test for the detection of SARS-CoV-2	3
Glycoconjugate content quantification to assess vaccine potency: A simplified approach	3
The role of real-world evidence for regulatory and public health decision-making for Accelerated Vaccine Deployment- a meeting report	3
Aims and Scope/Editorial Board/Publishing Details	3
From eradication to re-emergence: The changing landscape of polio in the cVDPV2 era	3
Enabling the evaluation of COVID-19 vaccines with correlates of protection	3
Assessment of the risks associated with the use of in vivo versus in vitro potency tests for vaccines	3
Maintaining the quality of vaccines through the use of standards: Current challenges and future opportunities	3
Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: Responses from a survey of National Control Laboratories and National Regulatory Authorities	3
Report for the Eighth Asian National Control Laboratory Network meeting in 2023: Self-sufficiency strategy of plasma-derived medicinal products and regulatory harmonisation	3
Risk assessment for biopharmaceutical single-use manufacturing: A case study of upstream continuous processing	3
Obituary - Inessa LEVENBOOK: 1926–2022	3
A vision for patient-centric specifications for biologicals	2
The current status of the biosimilars landscape in China	2
Klebsiella pneumoniae vaccine studies in animal models	2
A meta-analysis to re-evaluate the sensitivity and specificity of FMDV NSP ELISA tests	2
An optimized microplate-based method to evaluate complement-dependent hemolysis mediated by intravenous immunoglobulins (IVIG)	2
Development and optimization of multiplex PCR for rapid detection of type I-F1 and type I-F2 Cas cluster genes in Acinetobacter baumannii	2
Virus filtration using small pore virus filter in downstream processing of biotherapeutic products: The effect of operating pressure	2
A gaps-and-needs analysis of vaccine R&D in Europe: Recommendations to improve the research infrastructure	2
Evaluation of DF-1 cell culture based vaccine development for infectious bursal disease virus in Ethiopia	2
WHO informal consultation on revision of guidelines on evaluation of similar biotherapeutic products, virtual meeting, 30 June – 2 July 2021	2
Design and computational evaluation of a novel multi-epitope hybrid vaccine against monkeypox virus: Potential targets and immunogenicity assessment for pandemic preparedness	2
Similarity demonstrated between isolated charge variants of MB02, a biosimilar of bevacizumab, and Avastin® following extended physicochemical and functional characterization	2
Bacteriophage-based veterinary products: aligning regulatory framework and development challenges for market integration	2
Autogenous vaccines: Quality of production and movement in a common market	2
Evolution of FMT – From early clinical to standardized treatments	2
Accelerated national lot release on COVID-19 vaccines in Republic of Korea	2
Aims and Scope/Editorial Board/Publishing Details	2
Regulatory changes during the Covid-19 pandemic: A comparative review of the European Union and Brazilian regulations for biological and biotechnological products	2
Collaborative study on the cross-reactivity of two influenza B viral components in single radial immunodiffusion assay using quadrivalent influenza vaccines in Japan from 2015/16 to 2021–22 influenza	2

Aims and Scope/Editorial Board/Publishing Details	2
Development and evaluation of recombinant gD protein based ELISA for sero-surveillance of BoHV-1 in India	2
A practical approach for gmp-compliant validation of real-time PCR method for mycoplasma detection in human mesenchymal stromal cells as advanced therapy medicinal product	2
Expression and purification of Hepatitis B virus core antigen using Escherichia coli and its utilization for the diagnosis of Hepatitis B virus infections	2
Viral clearance capability of monoclonal antibody purification	2
Regulatory perspective for quality evaluation of lipid nanoparticle-based mRNA vaccines in China	2
Adjuvant effect of mesoporous silica SBA-15 on anti-diphtheria and anti-tetanus humoral immune response	2
Corrigendum to “Multiple factors shape technology transfer for the development and manufacture of vaccines in Latin America and the Caribbean” [Biologicals 90 (2025) 101826]	2
Molecular characterization of Anaplasma ovis Msp4 protein in strains isolated from ticks in Turkey: A multi-epitope synthetic vaccine antigen design against Anaplasma ovis using immunoinformatic tools	2
Canine parvovirus type 2 vaccines in Brazil: Viral load in commercial vaccine vials and phylogenetic analysis of the vaccine viruses	2
Advances in mRNA vaccine research in the field of quality control	2
Development and validation of a spectrophotometric method for quantification of residual cyclodextrin (DIMEB; Heptakis) in pertussis antigens	1
Efficient extraction of adventitious virus nucleic acid using commercially available methods	1
It is time to reconsider the use of naturally-occurring endotoxins in endotoxin recovery studies: Part 2 of a BioPhorum harmonized endotoxin recovery study	1
Corrigendum to “Comparison of Astra Zeneca and sinopharm vaccines as boosters in protection against COVID-19 infection” [Biologicals 82 (2023) 101668]	1
Emerging genetic diversity of SARS-CoV-2 RNA dependent RNA polymerase (RdRp) alters its B-cell epitopes	1
Antivenoms, hepatitis B vaccine and oral polio vaccine can be considered for storage and handling outside the cold chain following the innovative ‘controlled temperature chain’ approach	1
An alternative In vitro method for evaluation of inactivated infectious bronchitis (IB) vaccines	1
Multiple factors shape technology transfer for the development and manufacture of vaccines in Latin America and the Caribbean	1
Modeling the long-term 2-8 °C stability profiles of a live, rotavirus vaccine candidate (RV3-BB) in various liquid formulations via extrapolations of real-time and accelerated stability data	1
Emergence of SARS-CoV-2 variant of interest B.1.525 (Eta) in Bangladesh	1
Regulatory workshop on standardisation of clinical procedures, endpoints and data robustness of human challenge studies – A stakeholder meeting report	1
A collaborative study to establish the second national standard for antithrombin concentrate in Korea	1
An indirect ELISA for detecting anti-SARS-CoV-2 antibodies in human sera using a baculovirus-expressed recombinant nucleocapsid antigen	1
Report on the seventh meeting of national control laboratories for vaccines and biologicals of the WHO Western Pacific and South-East Asia member states	1
Aims and Scope/Editorial Board/Publishing Details	1
Adjuvant effects of novel water/oil emulsion formulations on immune responses against infectious bronchitis (IB) vaccine in mice	1
Histological and functional exploration of platelet activity post-SARS-CoV-2 vaccination	1
Fourth Controlled Human Infection Model (CHIM) meeting – CHIMs in endemic countries, May 22–23, 2023	1
Development and characterization of mouse monoclonal antibodies to canine morbillivirus	1
Report on the GHPP-BloodTrain online workshop on “Authorisation and Licensing of Blood Establishments - Review of quality documentation of blood and blood components”, 5th-8th of July 2021	1
Zoonoses Anticipation and Preparedness Initiative, stakeholders conference, February 4 & 5, 2021	1
Overview of regulatory frameworks on the national lot release of plasma-derived medicinal products in Korea	1
Aims and Scope/Editorial Board/Publishing Details	1
Expression, purification, and immunogenicity study of human papillomavirus type 52 virus-like particles produced in Hansenula polymorpha	1
Molecular characteristics of feline coronavirus in South Korea, 2016–2023	1